![Ashoo Gupta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 466 315 $ in data 31/05/2026
Ashoo Gupta is Controller & Vice President-Finance at 4D Molecular Therapeutics, Inc. since 2026.
Formerly, Mr. Gupta was Vice President-Finance & Controller at Kyverna Therapeutics, Inc. from 2023 to 2024.
Mr. Gupta completed undergraduate education at the University of Mumbai.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/03/2026 | 47.055 ( 0,09% ) | 466 315 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2024 |
| Società | Posizione | Fine |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
